Document Detail


Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.
MedLine Citation:
PMID:  20166993     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The significance of cytoprotection and adaptive cytoprotection and the peptides importance remained to be not completely determined. BPC 157 is an anti-ulcer peptidergic agent, proven in clinical trials to be both safe in inflammatory bowel disease (PL-10, PLD-116, PL 14736) and wound healing, and stable in human gastric juice, with no toxicity being reported. It has a prominent effect on alcohol- lesions (i.e., induced acutely and chronically) and non-steroidal anti-inflammatory drugs-lesions (while interestingly BPC 157 may both prevent and reverse adjuvant arthritis). To review the importance of BPC 157, this review focused on Robert's cytoprotection concept described in rat stomach, reviewing our evidence that may resolve whether the cytoprotection and adaptive cytoprotection is an uniform phenomenon or not; whether the phenomenon or phenomena are endogenous or not, depending on nature of the irritants (mild or strong); whether this may contribute to stomach mucosa defense either when threaten by various ulcerogens or afforded by various antiulcer agents; whether these phenomena are uniform in whole gastrointestinal tract or not; whether they are interrelated or not. Finally, the importance of the cytoprotection phenomena and cytoprotection activity for skin wound healing, and wound healing in general was challenged. Thereby, this review focused on BPC 157 role in cytoprotection and adaptative cytoprotection suggesting that it may be the essential endogenous mediator able to mediate both cytoprotective and adaptive cytoprotective response in stomach and the whole gastrointestinal tract with significant importance in wound healing as well.
Authors:
Predrag Sikiric; Sven Seiwerth; Luka Brcic; Marko Sever; Robert Klicek; Bozo Radic; Domagoj Drmic; Spomenko Ilic; Danijela Kolenc
Related Documents :
20402763 - Hepatocyte growth factor activator (hgfa): pathophysiological functions in vivo.
11470453 - The corneal wound healing response: cytokine-mediated interaction of the epithelium, st...
20844763 - Alphavirus replicon particles expressing trp-2 provide potent therapeutic effect on mel...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current pharmaceutical design     Volume:  16     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2010  
Date Detail:
Created Date:  2010-05-27     Completed Date:  2010-08-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1224-34     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Medical Faculty University of Zagreb, Salata 11, POB 916, 10000 Zagreb, Croatia. sikiric@mef.hr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Ulcer Agents / pharmacology*,  therapeutic use
Cytoprotection*
Gastric Acid / chemistry
Gastrointestinal Tract / pathology
Humans
Inflammatory Bowel Diseases / drug therapy,  pathology
Peptide Fragments / pharmacology*,  therapeutic use
Proteins / pharmacology*,  therapeutic use
Rats
Stomach Ulcer / drug therapy
Wound Healing / drug effects
Chemical
Reg. No./Substance:
0/Anti-Ulcer Agents; 0/Peptide Fragments; 0/Proteins; 137525-51-0/BPC 157

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of Dietary Fiber in Formation and Prevention of Small Intestinal Ulcers Induced by Nonsteroidal...
Next Document:  Complexity of Gastric Acid Secretion Revealed by Targeted Gene Disruption in Mice.